| 产品描述: | JZP-MA-11 is a positron emission tomography (PET) ligand targeting the endocannabinoid α/β-hydrolase domain 6 (ABHD6) enzyme. JZP-MA-11 selectively inhibits ABHD6 with an IC50 value of 126 nM. JZP-MA-11 can cross the blood-brain barrier (BBB). [18F]JZP-MA-11 has the potential for preclinical evaluation targeting the brain ABHD6 in mice and nonhuman primate (NHP). |
| 体外研究: |
JZP-MA-11 (1.5 mg/kg; 静脉给药; 示踪剂注射前 20 分钟) 导致大脑、肝脏、心脏和肾脏等富含 ABHD6 的器官的放射性摄取减少[1]。 |
| 体内研究: |
JZP-MA-11 (10 μM) 对表达 CB1 或 CB2 的 HEK293 细胞中 Forskolin.html" class="link-product" target="_blank">毛喉素 刺激的 cAMP 没有影响。 |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.973 ml |
14.864 ml |
29.728 ml |
| 5 mM |
0.595 ml |
2.973 ml |
5.946 ml |
| 10 mM |
0.297 ml |
1.486 ml |
2.973 ml |
| 50 mM |
0.059 ml |
0.297 ml |
0.595 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |